Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia
Author:
Dubinski Ilja1ORCID, Bechtold Dalla-Pozza Susanne1, Bidlingmaier Martin2, Reisch Nicole2, Schmidt Heinrich1
Affiliation:
1. Division for Pediatric Endocrinology , Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich , Munich , Germany 2. Department of Medicine IV , University Hospital, LMU Munich , Munich , Germany
Abstract
Abstract
Objectives
Children with salt-wasting congenital adrenal hyperplasia (CAH) have an impaired function of steroid synthesis pathways. They require therapy with glucocorticoid (GC) and mineralocorticoid hormones to avoid salt-wasting crisis and other complications. Most commonly, children receive hydrocortisone thrice daily with the highest dose in the morning, mimicking the regular physiology. However, reverse circadian treatment (RCT) had been suggested previously. In this study, we aimed to determine the efficacy of RCT in prepubertal children with CAH by comparing the salivary 17-hydroxyprogesterone (s17-OHP) levels individually.
Methods
In this retrospective study, we analyzed the records of children with classical CAH and RCT who were monitored by s17-OHP levels. The study included 23 patients. We identified nine prepubertal children with RCT schemes (three boys and six girls) and compared the s17-OHP levels in the morning, afternoon, and evening. The objective of this study was to demonstrate the non-effectiveness of RCT in terms of lowering the morning s17-OHP concentration. In addition, we compared s17-OHP day profiles in six patients on RCT and non-RCT therapy (intraindividually).
Results
Eight of nine children with RCT showed higher s17-OHP levels in the morning compared to the evening. In addition, none of the children showed a significant deviation of development. Three children were overweight. No adrenal crisis or pubertal development occurred. Comparison of RCT and non-RCT regimens showed no difference in 17-OHP profiles.
Conclusions
Our data do not support the use of RCT schemes for GC replacement in children with CAH due to lack of benefits and unknown long-term risks.
Publisher
Walter de Gruyter GmbH
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health
Reference28 articles.
1. El-Maouche, D, Arlt, W, Merke, DP. Congenital adrenal hyperplasia. Lancet 2017;390:2194–210. https://doi.org/10.1016/s0140-6736(17)31431-9. 2. White, PC, Speiser, PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245–91. https://doi.org/10.1210/edrv.21.3.0398. 3. Völkl, TM, Simm, D, Beier, C, Dörr, HG. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 2006;117:e98–105. https://doi.org/10.1542/peds.2005-1005. 4. Speiser, PW, Arlt, W, Auchus, RJ, Baskin, LS, Conway, GS, Merke, DP, et al.. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 2018;103:4043–88. https://doi.org/10.1210/jc.2018-01865. 5. Arlt, W, Willis, DS, Wild, SH, Krone, N, Doherty, EJ, Hahner, S, et al.. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110–21. https://doi.org/10.1210/jc.2010-0917.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|